1. Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers
   Takeshi Masuda et al, 2021, Drug Metabolism and Pharmacokinetics CrossRef
2. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients
   Akira Yamamoto et al, 2021, Surgery Today CrossRef
3. Leucine-Rich Alpha-2-Glycoprotein 1 in Serum Is a Possible Biomarker to Predict Response to Preoperative Chemoradiotherapy for Esophageal Cancer
   Madoka Nambu et al, 2019, Biological and Pharmaceutical Bulletin CrossRef
4. High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy
   Yang Hai et al, 2018, BMC Cancer CrossRef
5. Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo
   Yongshun Li et al, 2019, Bioscience Reports CrossRef
6. C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
   Peter C. Hart et al, 2020, Frontiers in Immunology CrossRef
7. The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study
   Jing Hu et al, 2022, Frontiers in Oncology CrossRef
8. Diagnostic Utility of Neutrophil - Lymphocyte Ratio in Head and Neck Cancers
   Sridhar Reddy Erugula et al, 2020, Journal of Evidence Based Medicine and Healthcare CrossRef
9. Changes in CRP and CA19-9 during Preoperative Oncological Therapy Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma
   Anna Maria Nurmi et al, 2021, Oncology CrossRef
10. Circulating biomarkers of response to immunotherapy and immune-related adverse events
    Zachary Garrison et al, 2022, Expert Review of Molecular Diagnostics CrossRef